Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2012
04/25/2012EP1356277B1 Method for altering cell fate
04/25/2012CN102428179A 用于增强t细胞功能的方法 Methods for enhancing the t-cell function
04/25/2012CN102423493A 一种可高效高特异灭杀乳腺癌细胞的药物 One kind can efficiently kill human breast cancer cells highly specific drug
04/25/2012CN102423489A 组织蛋白酶l抑制剂在制备放疗增敏药物中的应用 Cathepsin inhibitors in the preparation of l radiosensitization drug application
04/25/2012CN101940795B DLK1基因的用途以及siRNA、BM-MSCs和FGF2 DLK1 gene use and siRNA, BM-MSCs and FGF2
04/25/2012CN101818132B Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof
04/24/2012US8163896 Bioinformatically detectable group of novel regulatory genes and uses thereof
04/24/2012US8163892 Oncolytic virus replicating selectively in tumor cells
04/24/2012US8163710 Reduction of graft-versus-host disease by modulation of SHIP activity
04/24/2012US8163709 TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS
04/24/2012US8163708 Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
04/24/2012US8163691 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
04/24/2012US8163548 Recombinant bicistronic flaviviruses and methods of use thereof
04/24/2012US8163536 Apparatus for use in the propagation of pluripotent cells
04/24/2012US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins
04/24/2012US8163494 Method for assessing metastatic properties of breast cancer
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163292 Herpes simplex viruses and methods of viral replication
04/24/2012CA2539256C Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
04/24/2012CA2466244C Methods and apparatus for production of a micro-organ
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/24/2012CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1)
04/19/2012WO2012051459A1 Nucleic acid delivery compounds
04/19/2012WO2012051458A1 Nucleic acid delivery compounds
04/19/2012WO2012051457A1 Nucleic acid delivery compounds
04/19/2012WO2012051431A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012WO2012051343A1 Methods and compositions for treating hemophilia b
04/19/2012WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012WO2012050181A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012WO2012049665A1 A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy
04/19/2012WO2012049338A1 Dendrimers based on pamam derivatized with alkyl sulfonyl groups
04/19/2012WO2012049314A1 Expression vector for cholesterol 24 -hydrolase in therapy of huntington' s disease
04/19/2012WO2012015937A9 Parp1 targeted therapy
04/19/2012WO2011159970A3 Method for predicting a therapy response in subjects with multiple sclerosis
04/19/2012WO2011146788A3 Methods of assessing a risk of developing necrotizing meningoencephalitis
04/19/2012WO2011133216A3 Mutant nis protein and uses thereof
04/19/2012WO2011127337A3 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
04/19/2012WO2011123745A3 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
04/19/2012WO2011115810A3 Isoform-specific rnai based on codon redundancy/degeneracy
04/19/2012WO2011113030A3 Human cancer micro-rna expression profiles predictive of chemo-response
04/19/2012US20120095558 Synthetic bone grafts constructed from carbon foam materials
04/19/2012US20120095557 Dermal micro-organs, methods and apparatuses for producing and using the same
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095080 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120093913 Inhibition of SYK kinase expression
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093788 Protease for wound conditioning and skin care
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093777 Compositions comprising viruses and methods for concentrating virus preparations
04/19/2012US20120093775 Methods and compositions for the treatment of cirrhosis and liver fibrosis
04/19/2012US20120093774 Auxotrophic recombinant bcg strain pasteur and use thereof in the control of human infections caused by parasites
04/19/2012US20120093772 Vectors for delivery of light sensitive proteins and methods of use
04/19/2012CA2814698A1 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012CA2814143A1 Methods and compositions for treating hemophilia b
04/19/2012CA2813163A1 Prophylactic or therapeutic agent for fibrosis
04/18/2012EP2441474A1 Methods and compositions for modulating adipocyte function
04/18/2012EP2440251A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
04/18/2012EP2440183A1 Improved lipid formulation
04/18/2012EP1499358B1 Ph-sensitive polymer
04/18/2012EP0618925B2 Antisense oligonucleotides
04/18/2012CN102421902A Piggybac transposon variants and methods of use
04/18/2012CN102421894A Compositions, kits and methods for promoting ischemic and diabetic wound healing
04/18/2012CN102417912A 猪细小病毒样颗粒b细胞表位插入位点的分子设计 Porcine parvovirus-like particles b-cell epitope insertion site of Molecular Design
04/18/2012CN102417907A 靶向抑制羊痘病毒ORF095基因的siRNA序列 SiRNA sequences targeting inhibition of sheep pox virus ORF095 gene
04/18/2012CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha
04/18/2012CN102416203A 具有局部抗血小板效应的rna干扰血管支架涂层材料及其制成的局部抗凝血管支架 Rna with local anti-platelet effect of interference stent coating material and stent made of anticoagulation
04/18/2012CN102416185A miR29在制备抗流感病毒药物中的应用 miR29 in the preparation of anti-influenza virus drug application
04/18/2012CN102416184A microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用 microRNA-1 antisense nucleotide application lock sequence in the preparation of the prevention or treatment of heart failure after myocardial infarction medicine
04/18/2012CN102416183A miR-297b的用途 miR-297b use
04/18/2012CN102416182A miR-574-5p的用途 miR-574-5p use
04/18/2012CN102416173A 预防与猪环状病毒-2相关的心肌炎、流产和宫内感染 Prevention and porcine circovirus -2 associated myocarditis, abortion and intrauterine infection
04/18/2012CN101851624B 胰高血糖素受体基因的rna干扰序列 Glucagon receptor interference rna gene sequence
04/18/2012CN101851621B 一种微生物的分子标记及其构建和应用 Molecular marker of its construction and application of microbial
04/18/2012CN101792762B 特异性调节pokemon基因表达的反义寡核苷酸及其应用 Pokemon specific regulation of gene expression and its application of antisense oligonucleotides
04/18/2012CN101732730B 含咪唑嗡盐和大环多胺的阳离子脂质、转基因载体及制备方法 Om imidazole-containing macrocyclic polyamine salts and cationic lipids, gene transfer vector and preparation methods
04/18/2012CN101624422B 日本血吸虫重组多表位抗原及其表达、纯化方法与应用 Schistosoma japonicum and its multi-epitope recombinant expression, purification methods and applications
04/18/2012CN101538574B 一种密码子优化的霍乱肠毒素ctb基因及其霍乱核酸疫苗 One kind of codon optimized cholera toxin and cholera ctb gene DNA vaccine
04/18/2012CN101522222B Identification of a micro-RNA that activates expression of beta-myosin heavy chain
04/18/2012CN101489566B Aha基因的RNAi调控及其治疗性应用 RNAi Regulation and therapeutic applications Aha gene
04/17/2012US8158600 Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15)
04/17/2012US8158599 Chimeric adenoviruses for use in cancer treatment
04/17/2012US8158596 Materials and methods for FOXP3 tumor suppression
04/17/2012US8158594 CYP1B1 nucleic acids and methods of use
04/17/2012US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy
04/17/2012US8158418 Chimeric alphavirus replicon particles
04/17/2012US8158416 CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
04/17/2012US8158413 Lentiviral vector-based vaccine
04/17/2012US8158341 Efficient algorithm for PCR testing of blood samples
04/17/2012US8158121 Cardiac muscle regeneration using mesenchymal stem cells
04/17/2012US8158120 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
04/17/2012CA2506672C Il-23 for treating cutaneous wounds
04/17/2012CA2493323C Dual reporter gene assay
04/17/2012CA2408328C Immunogenic polypeptides encoded by mage minigenes and uses thereof
04/17/2012CA2377607C Neurotrophic factor receptor
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 870